REFILE-Teva sets final price terms for SFr1bn bond deal

LONDON, July 21 (IFR) - Teva Pharmaceutical has set final

price terms for a SFr1bn three-tranche bond issue to help fund

its US$40.5bn acquisition of Actavis Generics, according to a

lead bank.

Read more